Vincenzo De Angelis: Presenting Trends and Challenges in Blood and Plasma Collection and Use in Europe
Vincenzo De Angelis, President of European School of Transfusion Medicine (ESTM), shared a post on LinkedIn:
“Honoured to be invited at the 8th Congress of Transfusion Medicine of Serbia to present, on behalf of the ESTM, on Trends and Challenges in Blood and Plasma Collection and Use in Europe.
Red blood cell demand remains substantial but is increasingly influenced by Patient Blood Management strategies, while platelet utilisation continues to grow because of advanced oncological and haematological treatments.
Plasma has emerged as a strategic healthcare resource, yet Europe remains dependent on imports for approximately 40% of plasma required for fractionation.
Major challenges include ageing donor populations, recruitment and retention of younger donors, logistical complexity, economic pressures, ethical debates concerning donor compensation, and the need for stronger European strategic autonomy.
Welcome the new SoHO Regulation (EU) 2024/1938.”
Stay updated with Hemostasis Today.
-
Nov 6, 2026, 22:50Alexis Caulier: Leveraging Epigenetic Silencing in HSCs to Modulate Platelet Aggregation
-
Nov 6, 2026, 22:40Panama Achieves Self-Sufficiency in Haemophilia Care – Novo Nordisk Haemophilia and Haemoglobinopathies Foundation
-
Nov 6, 2026, 22:31Luisa Weiss: Exploring the Role of Platelets and Extracellular Vesicles in Calcific Aortic Valve Disease
-
Nov 6, 2026, 22:29Nour Al-Mozain: The Role of Therapeutic Apheresis and Cell Therapy in Advancing Regional Practice
-
Nov 6, 2026, 22:28Moazzam Shahzad: Celebrating Mentees Receiving the 2026 ASH Abstract Achievement Award
-
Nov 6, 2026, 22:25Habib Bennaceur: Self-Sufficiency in Haemophilia Care – A Major Achievement for Panama
-
Nov 6, 2026, 22:25Alessandro Lucchesi: Engineering Disease Trajectories in Myeloproliferative Neoplasms at RiseMPN 2026
-
Nov 6, 2026, 22:24Davood Bava: A New Practical Handbook for Advances in Transfusion Medicine
-
Nov 6, 2026, 22:15Dmitrii Kalinin: Allosteric Anticoagulation – An Alternative Strategy for Safer, Next-Generation Anticoagulants